|
| U.S. Brand
Names |
|
| AK-Pentolate®; Cyclogyl®;
I-Pentolate® |

|
|
| Generic
Available |
|
|
No |

|
|
| Synonyms |
|
|
Cyclopentolate Hydrochloride |

|
|
| Pharmacological Index |
|
|
Anticholinergic Agent, Ophthalmic |

|
|
| Use |
|
|
Diagnostic procedures requiring mydriasis and
cycloplegia |

|
|
| Pregnancy Risk
Factor |
|
|
C |

|
|
| Contraindications |
|
|
Narrow-angle glaucoma, known hypersensitivity to drug |

|
|
| Warnings/Precautions |
|
|
2% solution may result in psychotic reactions and behavioral disturbances in
children, usually occurring approximately 30-45 minutes after instillation; use
with caution in elderly patients and other patients who may be predisposed to
increased intraocular pressure |

|
|
| Adverse
Reactions |
|
|
1% to 10%:
Central nervous system: Restlessness, hallucinations, psychosis,
hyperactivity, seizures, incoherent speech, ataxia
Dermatologic: Burning sensation
Ocular: Increase in intraocular pressure, loss of visual accommodation
Miscellaneous: Allergic reaction |

|
|
| Overdosage/Toxicology |
|
|
Antidote, if needed, is pilocarpine |

|
|
| Drug
Interactions |
|
|
Decreased effect of carbachol, cholinesterase inhibitors |

|
|
| Stability |
|
|
Store in tight containers |

|
|
| Mechanism of
Action |
|
|
Prevents the muscle of the ciliary body and the sphincter muscle of the iris
from responding to cholinergic stimulation, causing mydriasis and
cycloplegia |

|
|
| Pharmacodynamics/Kinetics |
|
|
Peak effect: Cycloplegia: 25-75 minutes; Mydriasis: 30-60 minutes
Duration: Recovery takes up to 24 hours |

|
|
| Usual Dosage |
|
|
Ophthalmic:
Children: Instill 1 drop of 0.5%, 1%, or 2% in eye followed by 1 drop of 0.5%
or 1% in 5 minutes, if necessary
Adults: Instill 1 drop of 1% followed by another drop in 5 minutes; 2%
solution in heavily pigmented iris |

|
|
| Administration |
|
|
To avoid excessive systemic absorption, finger pressure should be applied on
the lacrimal sac during and for 1-2 minutes following
application |

|
|
| Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
|
No information available to require special precautions |

|
|
| Dental Health:
Effects on Dental Treatment |
|
|
No effects or complications reported |

|
|
| Patient
Information |
|
|
May cause blurred vision and increased sensitivity to
light |

|
|
| Nursing
Implications |
|
|
Finger pressure should be applied to lacrimal sac for 1-2 minutes after
instillation to decrease risk of absorption and systemic
reactions |

|
|
| Dosage Forms |
|
|
Solution, ophthalmic, as hydrochloride: 0.5% (2 mL, 5 mL, 15 mL); 1% (2 mL, 5
mL, 15 mL); 2% (2 mL, 5 mL, 15
mL) |

|
|
Copyright © 2007 Drugs Area
|